We are live on ! Find out more
AI

Atom Investors Portfolio holdings

AUM $1.4B
1-Year Est. Return 23.77%
This Fund
S&P 500
This Quarter Est. Return
-6.62%
1 Year Est. Return
+23.77%
3 Year Est. Return
+63.44%
5 Year Est. Return
+52.26%
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$382M
Cap. Flow
-$359M
Cap. Flow %
-167.72%
Top 10 Hldgs %
41.47%
Holding
364
New
100
Increased
28
Reduced
50
Closed
178

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$4.52M
2
GLHA
Glass Houses Acquisition Corp. Class A common stock
GLHA
+$4.44M
3
V icon
Visa
V
+$3.37M
4
SUMO
Sumo Logic, Inc. Common Stock
SUMO
+$3.05M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$3.01M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$14.5M
2
IBB icon
iShares Biotechnology ETF
IBB
+$12.8M
3
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$5.34M
4
TGT icon
Target
TGT
+$4.81M
5
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$4.13M

Sector Composition

Rank Sector Weight
1 Financials 16.09%
2 Healthcare 9.62%
3 Industrials 7.63%
4 Technology 6.82%
5 Consumer Discretionary 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGMS
176
Bio Green Med Solution Inc
BGMS
$4.91M
$96K 0.04%
+9
New +$109K
BNTC icon
177
Benitec Biopharma
BNTC
$402M
$87K 0.04%
+2,196
New +$91K
CRDF icon
178
Cardiff Oncology
CRDF
$66.5M
$84K 0.04%
+33,798
New +$120K
GLHAW
179
CALL
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$79K 0.04%
+231,624
New +$102K
STXS icon
180
Stereotaxis
STXS
$126M
$77K 0.04%
+20,549
New +$97K
BINI
181
DELISTED
Bollinger Innovations
BINI
– –
0
– –
ELOX
182
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$63K 0.03%
2,829
– –
ALT icon
183
Altimmune
ALT
$552M
$62K 0.03%
+10,109
New +$74.4K
PRQR icon
184
ProQR Therapeutics
PRQR
$243M
$28K 0.01%
+30,422
New +$102K
CALA
185
DELISTED
Calithera Biosciences, Inc
CALA
$27K 0.01%
3,391
+1,082
+47% +$11.1K
CEI
186
DELISTED
Camber Energy, Inc
CEI
$22K 0.01%
518
-167
-24% -$6.12K
AAPL icon
187
Apple
AAPL
$4.54T
– –
-9,467
Closed -$1.68M
ABBV icon
188
AbbVie
ABBV
$443B
– –
-15,389
Closed -$2.08M
ADV icon
189
Advantage Solutions
ADV
$522M
– –
-648
Closed -$130K
ALBT
190
DELISTED
Avalon GloboCare
ALBT
– –
-107
Closed -$13K
ALHC icon
191
Alignment Healthcare
ALHC
$3.08B
– –
-23,589
Closed -$332K
ALIT icon
192
Alight
ALIT
$447M
– –
-6,343
Closed -$1.37M
ALXO icon
193
ALX Oncology
ALXO
$261M
– –
-15,477
Closed -$333K
AMAT icon
194
Applied Materials
AMAT
$403B
– –
-1,893
Closed -$298K
AMD icon
195
Advanced Micro Devices
AMD
$776B
– –
-4,361
Closed -$628K
AMED
196
DELISTED
Amedisys
AMED
– –
-3,184
Closed -$515K
AMP icon
197
Ameriprise Financial
AMP
$48.3B
– –
-5,853
Closed -$1.77M
APO icon
198
Apollo Global Management
APO
$72.4B
– –
-3,239
Closed -$235K
ARCC icon
199
Ares Capital
ARCC
$13.5B
– –
-12,200
Closed -$259K
ARKK icon
200
ARK Innovation ETF
ARKK
$5.66B
– –
-10,857
Closed -$1.03M
6 7
8
9 10

Similar funds

SP
Steelhead Partners Seattle, Washington $1.39B AUM 0.01% 1-Year Est. Return
ELC
Edgar Lomax Company Kingstowne, Virginia $1.4B AUM 20.67% 1-Year Est. Return
HRES
Heitman Real Estate Securities Chicago, Illinois $1.39B AUM 6.59% 1-Year Est. Return
SRAIM
Scheer Rowlett & Associates Investment Management Toronto, Ontario, Canada $1.39B AUM 49.24% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.39B AUM 18.33% 1-Year Est. Return
TCC
Trans-Canada Capital Montreal, Quebec, Canada $1.39B AUM 16.61% 1-Year Est. Return
FCP
Fidelis Capital Partners Tampa, Florida $1.4B AUM 31.16% 1-Year Est. Return
SC
Sagefield Capital Dallas, Texas $1.39B AUM 60.14% 1-Year Est. Return

Atom Investors's Q1 2022 Portfolio in Review

As of Q1 2022, Atom Investors held 364 positions worth $214M, down 64% from $596M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Atom Investors withdrew a net $359M in Q1 2022, closing 178 positions and reducing 50 holdings. Its most notable exit was Target, an estimated $4.81M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 6.7% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Atom Investors opened a new position in Bank of America worth $4.13M.

  • Atom Investors's largest Q1 2022 buy was Bank of America: 100,195 shares worth $4.13M.
  • Atom Investors added most to Visa in Q1 2022, an estimated $3.37M increase.
  • Atom Investors's biggest Q1 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $14.5M.
  • Atom Investors fully exited Target in Q1 2022, selling an estimated $4.81M.
  • Atom Investors's ten largest holdings make up 41% of its $214M portfolio in Q1 2022.
  • Atom Investors opened 100 new positions and closed 178 in Q1 2022.
  • Atom Investors's portfolio value fell 64% quarter-over-quarter to $214M.

Based on Atom Investors's 13F filing for Q1 2022, filed 16 May 2022.